SCHEMBL13696472

SCHEMBL13696472

COc1cc(Cl)c(C)cc1N=C=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.53
▸ CYP3A4 P08684 3/20 0.53
▸ TDP1 Q9NUW8 3/20 0.53
▸ HPGD P15428 2/20 0.53
▸ GLA P06280 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ TRPA1 O75762 1/20 0.40
▸ KMT2A Q03164 4/20 0.38
▸ KDM4E B2RXH2 4/20 0.38
▸ LMNA P02545 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ HTT P42858 1/20 0.35
▸ MAPK1 P28482 1/20 0.34
▸ PMM2 O15305 1/20 0.34
▸ G6PD P11413 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29796039 0.93 ALDH1A1 (0.53) ALDH1A1CYP3A4TDP1HPGDGLA
SCHEMBL23214234 0.93 ALDH1A1 (0.53) ALDH1A1CYP3A4TDP1HPGDGLA
SCHEMBL6371043 0.86 ALDH1A1 (0.49) ALDH1A1CYP3A4TDP1HPGDGLA
SCHEMBL3993039 0.86 ALDH1A1 (0.56) ALDH1A1CYP3A4TDP1HPGDTSHR
SCHEMBL9825110 0.84 CYP3A4 (0.58) ALDH1A1CYP3A4TDP1HPGDTRPA1
SCHEMBL6372027 0.84 CYP3A4 (0.58) ALDH1A1CYP3A4TDP1HPGDTSHR
SCHEMBL7159670 0.82 ALDH1A1 (0.56) ALDH1A1CYP3A4TDP1HPGDTRPA1
SCHEMBL1457541 0.82 ALDH1A1 (0.56) ALDH1A1CYP3A4TDP1HPGDTRPA1
SCHEMBL542663 0.81 CYP3A4 (0.68) ALDH1A1CYP3A4TDP1HPGDTSHR
SCHEMBL668344 0.81 ALDH1A1 (0.54) ALDH1A1CYP3A4TDP1HPGDTRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090234117-A1 Pyrazolopyrimidine Derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090234117-A1 Pyrazolopyrimidine Derivative MC2R, CRHR1, AVPR2 ALDH1A1 1328/4885CYP3A4 372/4885TDP1 3304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback